Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease.

Holden, Rachel M.
Booth, Sarah L.
Day, Andrew G.
Clase, Catherine M.
Zimmerman, Deborah.
Moist, Louise.
Shea, M Kyla.
McCabe, Kristin M.
Jamal, Sophie A.
Tobe, Sheldon.
Weinstein, Jordan.
Madhumathi, Rao.
Adams, Michael A.
Heyland, Daren K.
2015

Background Contexte: Cardiovascular disease, which is due in part to progressive vascular calcification, is the leading cause of death among patients with end stage kidney disease (ESKD) on dialysis. A role for vitamin K in the prevention of vascular calcification is plausible based on the presence of vitamin K dependent proteins in vascu... read more

Permanent URL
http://hdl.handle.net/10427/010102
Original publication
Holden, Rachel, Sarah L. Booth, Andrew G. Day, Catherine M. Clase, Deborah Zimmerman, Louise Moist, M. Kyla Shea, Kristin M. McCabe, Sophie A. Jamal, Sheldon Tobe, Jordan Weinstein, Rao Madhumathi, Michael A. Adams, and Daren K. Heyland. "Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease." Canadian Journal of Kidney Health and Disease 2, no. 1 (12, 2015): 1-8.
ID: tufts:17598
To Cite: DCA Citation Guide
Usage: Detailed Rights